Butterfly Network, Inc.
BFLYHealthcareNASDAQMedical Devices · Last scanned Jul 18, 2026
Scan Results
Daily timeframePart of the healthcare sector, Butterfly Network, Inc. (BFLY) is listed under Medical Devices. The $1.73B market capitalization puts BFLY squarely in small-cap range for its industry. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market.
Market Cap
$1.73B
Beta
2.05
P/E (TTM)
—
P/E (Fwd)
-71.57
EPS (TTM)
$-0.28
EPS (Fwd)
$-0.09
ROE
-35.2%
ROA
-11.2%
Cash
$138.0M
Total Debt
$19.8M
Free CF
$8.9M
52W Change
254.0%
Annual Financials
Cash vs Debt
The balance sheet looks solid with $138.0M in cash comfortably exceeding the $19.8M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow comes in at $8.9M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -35.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $62.6M (2021) to $97.6M (2025), reflecting a 56% increase over the period.
A beta of 2.05 means BFLY is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Butterfly Network, Inc.'s trajectory.